SCHEMBL1780897

SCHEMBL1780897

OCc1ccc(C2CCC3(CC2)OCCO3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 6/20 0.44
TRPV3 Q8NET8 1/20 0.36
IKBKE Q14164 1/20 0.36
TBK1 Q9UHD2 1/20 0.36
ESR1 P03372 2/20 0.36
ATP1A1 P05023 2/20 0.35
ATP1B1 P05026 2/20 0.35
ATP1A3 P13637 2/20 0.35
ATP1B2 P14415 2/20 0.35
ATP1A2 P50993 2/20 0.35
ATP1B3 P54709 2/20 0.35
FXYD2 P54710 2/20 0.35
ATP1A4 Q13733 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
SLC5A1 P13866 1/20 0.34
SLC5A2 P31639 1/20 0.34
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
C5AR1 P21730 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14403053 0.86 ESR2 (0.42) ESR2TRPV3IKBKETBK1ESR1
SCHEMBL6677219 0.83 ESR2 (0.37) ESR2TRPV3IKBKETBK1ESR1
Hydrochloric Acid SCHEMBL253113 0.82 ESR2 (0.36) ESR2TRPV3IKBKETBK1ESR1
SCHEMBL8990466 0.82 ESR2 (0.39) ESR2TRPV3IKBKETBK1ESR1
SCHEMBL25865053 0.81 DRD2 (0.44) ESR2TRPV3IKBKETBK1ATP1A1
SCHEMBL10131989 0.81 IKBKE (0.38) ESR2IKBKETBK1C5AR1ALDH1A1
SCHEMBL8383556 0.81 ESR2 (0.58) ESR2ESR1CYP3A4CYP2C9
SCHEMBL8451083 0.81 SPHK1 (0.43) C5AR1ALDH1A1MEN1KMT2A
SCHEMBL251729 0.78 ALDH1A1 (0.44) IKBKETBK1CYP2C9C5AR1ALDH1A1
SCHEMBL742590 0.78 ESR2 (0.52) ESR2ESR1CYP3A4CYP2C9CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2197551-B1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME (US) 2016-12-28 EP disclosed
US-8455638-B2 Soluble guanylate cyclase activators MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110118282-A1 Soluble Guanylate Cyclase Activators MERCK SHARP & DOHME LLC 2011-05-19 US disclosed
US-20090209556-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME CORP. 2009-08-20 US disclosed
US-5536725-A Insecticidal substituted-2,4-diamino-5,6,7,8-tetrahydroquinazolines FMC CORPORATION (US) 1996-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118282-A1 Soluble Guanylate Cyclase Activators GUCY1B1, GUCY1A2, GUCY1A1 ESR2 823/4885TRPV3 3291/4885IKBKE 964/4885
US-20090209556-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS GUCY1B1, GUCY1A2, GUCY1A1 ESR2 823/4885TRPV3 3291/4885IKBKE 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.